Cita APA (7a ed.)
Asenjo García, B., Navarro Guirado, F., Nagib Raya, F., Vidal Denis, M., Bravo Rodríguez, F., & Galán Montenegro, P. (2020). ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma. Acta Radiologica, 61(3), 404-414.
Cita Chicago Style (17a ed.)
Asenjo García, Beatriz, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríguez, y Pedro Galán Montenegro. "ADC Quantification to Classify Patients Candidate to Receive Bevacizumab Treatment for Recurrent Glioblastoma." Acta Radiologica 61, no. 3 (2020): 404-414.
Cita MLA (9a ed.)
Asenjo García, Beatriz, et al. "ADC Quantification to Classify Patients Candidate to Receive Bevacizumab Treatment for Recurrent Glioblastoma." Acta Radiologica, vol. 61, no. 3, 2020, pp. 404-414.
Precaución: Estas citas no son 100% exactas.